ENTITY
Sumitomo Pharma

Sumitomo Pharma (4506 JP)

72
Analysis
Health CareJapan
Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.
more
bullishSumitomo Pharma
03 Oct 2024 16:45

Sumitomo Pharma (4506 JP): Q1FY25 Result Shows Early Sign of Performance Reversal

Sumitomo Pharma shares gained 37% in just two months. Book partial profit and hold core position. Valuation is still cheap and outlook is still...

Logo
529 Views
Share
bearishSumitomo Pharma
02 May 2024 18:30

Sumitomo Pharma (4506 JP): FY24 Guidance Revised Lower; Further Cost Cuts in FY25 to Turn Profitable

Sumitomo Pharma raised FY24 operating loss guidance by ¥199B to ¥355B due to impairment loss. The company expects to turn profitable in FY25 via...

Logo
285 Views
Share
bullishSumitomo Pharma
19 May 2022 19:25

Sumitomo Dainippon Pharma Co (4506 JP): New Launches Ensure Post-Latuda Growth Trajectory

Sumitomo is on right track to alleviate patent cliff through new launches in the U.S. The company’s three new U.S. products have potential for...

Logo
389 Views
Share
bearishSumitomo Pharma
15 Jan 2024 09:30

Sumitomo Pharma (4506 JP): FY24 Guidance Seems to Be Aggressive; Downtrend Will Likely To Continue

​Sumitomo Pharma expects a significant decline in FY24 revenue. North America needs to bounce back to achieve their target. Without a strong...

Logo
342 Views
Share
08 May 2023 01:54

JAPAN GOVERNANCE CHANGES II - Who Could Surprise on Buybacks? Quant Rankings

JAPAN GOVERNANCE: There is a buyback story coming. It will be big. Bigger than the past year or two, and it will continue. What to buy?

Logo
870 Views
Share
x